French Registry of Acute Coronary Syndrome (Fast-MI)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
French Cardiology Society
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT00673036
First received: May 5, 2008
Last updated: October 14, 2014
Last verified: October 2014

May 5, 2008
October 14, 2014
October 2005
December 2016   (final data collection date for primary outcome measure)
All causes mortality at each follow-up period [ Time Frame: 6 months, each year ] [ Designated as safety issue: Yes ]
Same as current
Complete list of historical versions of study NCT00673036 on ClinicalTrials.gov Archive Site
  • Cardiovascular mortality [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • validation of guidelines across the country [ Time Frame: 6 month, each year ] [ Designated as safety issue: No ]
  • Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes [ Time Frame: 6 month each year ] [ Designated as safety issue: No ]
  • Serum databank for evaluation of biomarkers in MI [ Time Frame: 6 month each year ] [ Designated as safety issue: No ]
  • Cardiovascular mortality [ Time Frame: 6 month, each year ] [ Designated as safety issue: Yes ]
  • validation of guidelines accross the country [ Time Frame: 6 month, each year ] [ Designated as safety issue: No ]
  • Pharmacogenetic and cardiovascular genetic studies associated to clinical outcomes [ Time Frame: 6 month each year ] [ Designated as safety issue: No ]
  • Serum databank for evaluation of biomarkers in MI [ Time Frame: 6 month each year ] [ Designated as safety issue: No ]
Not Provided
Not Provided
 
French Registry of Acute Coronary Syndrome
French Registry of Acute Coronary Syndrome With or Without ST Elevation

The Fast-MI registry was designed to evaluate the "real world" management of patients with acute myocardial infarction (MI), and to assess their in-hospital, medium and long-term outcomes

Primary objectives : compare survival following the admission to a USIC according to the terms of care

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

Whole blood, serum and DNA

Non-Probability Sample

Admitted patients in a Unit of Coronary Intensive Care (USIC) for a acute coronary syndrome

Acute Myocardial Infarction
Other: Blood sample
60 ml of whole blood
Other Name: Blood sample
1
Adults (female and male) with a acute coronary syndrome
Intervention: Other: Blood sample

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
3750
December 2017
December 2016   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • admission within the 48 hours after the occurence of acute myocardial infarction (AMI)
  • written informed consent for the DNA and serum databank

Exclusion Criteria:

  • AMI occured within the 48 hours after therapeutic intervention (bypass, coronary angioplasty or other chirurgical intervention)
  • diagnostic of AMI not confirmed
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00673036
04-1244
No
Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
French Cardiology Society
Principal Investigator: Nicolas DANCHIN, MD PH Assistance Publique - Hôpitaux de Paris
Assistance Publique - Hôpitaux de Paris
October 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP